Evidence map›Paper›PMID 31987614›Full record

ArticleThe Journal of thoracic and cardiovascular surgery2021

Commentary: Nitric oxide: An important contributor to neuroprotection during pediatric cardiac surgery.

Nobuyuki Ishibashi, Richard A Jonas

Abstract readEditorialComment
In one paragraph

Article in The Journal of thoracic and cardiovascular surgery, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Nobuyuki IshibashiDivision of Cardiovascular Surgery, Center for Neuroscience Research, and Sheikh Zayed Institute for Pediatric Surgical Innovation, Children's National Hospital, Washington, DC. Electronic address: nishibas@childrensnational.org.
Richard A JonasDivision of Cardiovascular Surgery, Center for Neuroscience Research, and Sheikh Zayed Institute for Pediatric Surgical Innovation, Children's National Hospital, Washington, DC. Electronic address: rjonas@childrensnational.org.

Funding

Cell Therapy for Neuroprotection in Congenital Heart DiseaseR01HL139712 · NHLBI · CHILDREN'S RESEARCH INSTITUTE · PI Nobuyuki Ishibashi · 2018 to 2026
$5.7M
White Matter Protection in the Fetus with Congenital Heart DiseaseR01HL146670 · NHLBI · CHILDREN'S RESEARCH INSTITUTE · PI ISHIBASHI, NOBUYUKI · 2020 to 2023
$3.3M
NHLBI NIH HHS R01 HL139712NHLBI NIH HHS R01 HL146670
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cardiac Surgical ProceduresHypertension, PulmonaryChildHeartHumansNeuroprotectionNitric OxideNitric Oxide

Identifiers

PMID31987614
PMCPMC7538197

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.